Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Magda Marečková, Nuffield Department of Women's & Reproductive Health DPhil student, has won this year's special prize, the Special Young Scientist Award at the Fast Forward Science 2020 web-video competition. She wins for her compelling video: "Heavy periods, sharp pain and no one to listen to you? Could you have Endometriosis?".

The web-video competition Fast Forward Science is a joint project of Wissenschaft im Dialog and the Stifterverband. It has been held annually since 2013. Prizes with a total value of € 21,500 will be awarded in 2020. The partner in the VISION category and of the Young Scientist Award is the Deutscher Zukunftspreis, the German President’s Award for Innovation in Science and Technology.

Fast Forward Science encourages students, communicators, researchers, web video makers and those interested in science to submit compelling web videos on scientific topics. The challenge: The videos should be entertaining, scientifically accurate and easy to understand at the same time. The aim is to make science web videos more visible. Web videos are an excellent way to communicate about scientific topics and are suitable for reaching large audiences. By enhancing their visibility and showcasing excellence, it will encourage more people to use them to communicate science.

Magda Marečková's wining video was awarded this year's Special Young Scientist Award. It shone a spotlight on Endometriosis  - a disease that is just as common as diabetes, but hardly anyone has heard of. Is there such a thing? It's a disease that affects 190 million women worldwide. This is associated with severe pain, but so far hardly researched. In her video, she explains what it is all about, the current state of research and how endometriosis is changing the lives of those affected.

Watch Magda's winning video here

The full story is available on the Nuffield Department of Women's & Reproductive Health website

 

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

Professor Trish Greenhalgh Highly Commended in the O²RB Excellence in Impact Awards 2021

Congratulations to Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences) who has been Highly Commended in the O²RB Excellence in Impact Awards 2021.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.